- Home
- HSDT vs RSLS Comparison
HSDT vs RSLS Comparison
Compare HSDT & RSLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSDT
- RSLS
- Stock Information
- Founded
- HSDT 2014
- RSLS 2002
- Country
- HSDT United States
- RSLS United States
- Employees
- HSDT N/A
- RSLS N/A
- Industry
- HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- RSLS Medical/Dental Instruments
- Sector
- HSDT Health Care
- RSLS Health Care
- Exchange
- HSDT Nasdaq
- RSLS Nasdaq
- Market Cap
- HSDT 3.4M
- RSLS 3.2M
- IPO Year
- HSDT N/A
- RSLS 2007
- Fundamental
- Price
- HSDT $0.75
- RSLS $4.52
- Analyst Decision
- HSDT Buy
- RSLS Hold
- Analyst Count
- HSDT 2
- RSLS 1
- Target Price
- HSDT $24.00
- RSLS N/A
- AVG Volume (30 Days)
- HSDT 8.1M
- RSLS 21.9K
- Earning Date
- HSDT 11-12-2024
- RSLS 11-14-2024
- Dividend Yield
- HSDT N/A
- RSLS N/A
- EPS Growth
- HSDT N/A
- RSLS N/A
- EPS
- HSDT N/A
- RSLS N/A
- Revenue
- HSDT $502,000.00
- RSLS $8,183,000.00
- Revenue This Year
- HSDT N/A
- RSLS $17.47
- Revenue Next Year
- HSDT $8.97
- RSLS $20.00
- P/E Ratio
- HSDT N/A
- RSLS N/A
- Revenue Growth
- HSDT N/A
- RSLS N/A
- 52 Week Low
- HSDT $0.37
- RSLS $4.09
- 52 Week High
- HSDT $9.50
- RSLS $29.00
- Technical
- Relative Strength Index (RSI)
- HSDT 54.25
- RSLS 44.77
- Support Level
- HSDT $0.61
- RSLS $4.35
- Resistance Level
- HSDT $0.90
- RSLS $5.19
- Average True Range (ATR)
- HSDT 0.10
- RSLS 0.33
- MACD
- HSDT 0.00
- RSLS 0.04
- Stochastic Oscillator
- HSDT 48.76
- RSLS 21.18
About HSDT Helius Medical Technologies Inc. (DE)
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.
About RSLS ReShape Lifesciences Inc.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.